Zambon Outsources Production To Focus On Market Share

Italy-based multinational drugmaker Zambon has agreed a deal which will outsource the manufacturing of products in Brazil to Boehringer Ingelheim. The decision, which takes advantage of Boehringer Ingelheim's high-value Industrial Customer (IC) business, was made to allow Zambon to focus on core segments of research and marketing, according to the manager of IC in Brazil, Augusto Henrique Geraldi. BMI believes the move should benefit both

To read the full article, please choose one of the following options: